SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-15-009696
Filing Date
2015-05-11
Accepted
2015-05-11 15:57:45
Documents
10
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q insy20150331_10q.htm 10-Q 1056852
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 11516
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 11327
4 EXHIBIT 32 ex32.htm EX-32 9508
  Complete submission text file 0001437749-15-009696.txt   6047467

Data Files

Seq Description Document Type Size
5 EXHIBIT 101.INS insy-20150331.xml EX-101.INS 948371
6 EXHIBIT 101.SCH insy-20150331.xsd EX-101.SCH 39868
7 EXHIBIT 101.CAL insy-20150331_cal.xml EX-101.CAL 35959
8 EXHIBIT 101.DEF insy-20150331_def.xml EX-101.DEF 271910
9 EXHIBIT 101.LAB insy-20150331_lab.xml EX-101.LAB 224823
10 EXHIBIT 101.PRE insy-20150331_pre.xml EX-101.PRE 290458
Mailing Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044
Business Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044 602-910-2617
Insys Therapeutics, Inc. (Filer) CIK: 0001516479 (see all company filings)

IRS No.: 510327886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35902 | Film No.: 15850558
SIC: 2834 Pharmaceutical Preparations